Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of G αq protein-induced cardiomyopathy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 5, 2010, Pages

  Timofeyev, Valeriy ^a   Porter, Cliff A ^a   Tuteja, Dipika ^a   Qiu, Hong ^a   Li, Ning ^a   Tang, Tong ^c,d   Singapuri, Anil ^a   Han, Pyung Lim ^e   Lopez, Javier E ^a   Hammond, H Kirk ^c,d   Chiamvimonvat, Nipavan ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e Ewha Womans University School of Medicine   (South Korea)

Author keywords

Action potential; Hypertrophy; Mouse cardiac myocyte; Protein kinase C

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE TYPE 5; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; GENE DISRUPTION; GENE OVEREXPRESSION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POTASSIUM CURRENT; PRIORITY JOURNAL; SINUS BRADYCARDIA; SURVIVAL;

ADENYLATE CYCLASE; ANIMALS; BRADYCARDIA; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEART FAILURE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; PHENOTYPE; PROTEIN KINASE C;

EID: 78249284074     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01208.2009     Document Type: Article

References (50)

1. Braun MU, LaRosee P, Schon S, Borst MM, Strasser RH. Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat. Cardiovasc Res 56: 52-63, 2002.
2. Chen Y, Harry A, Li J, Smit MJ, Bai X, Magnusson R, Pieroni JP, Weng G, Iyengar R. Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation. Proc Natl Acad Sci USA 94: 14100-14104, 1997.
3. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5: 3037-3046, 1991.
4. Cooper DM. Molecular and cellular requirements for the regulation of adenylate cyclases by calcium. Biochem Soc Trans 31: 912-915, 2003.
5. αq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94: 8121-8126, 1997.
6. Dorn GW 2nd, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115: 527-537, 2005.
7. αq-overexpressing mice. Proc Natl Acad Sci USA 96: 6400-6405, 1999.
8. αq-mediated cardiac hypertrophy and ventricular dysfunction. Mol Pharmacol 57: 278-287, 2000.
9. Engelhardt S, Hein L, Wiesmann F, Lohse MJ. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96: 7059-7064, 1999.
10. Esposito G, Perrino C, Ozaki T, Takaoka H, Defer N, Petretta MP, De Angelis MC, Mao L, Hanoune J, Rockman HA, Chiariello M. Increased myocardial contractility and enhanced exercise function in transgenic mice overexpressing either adenylyl cyclase 5 or 8. Basic Res Cardiol 103: 22-30, 2008.
11. Freeman K, Lerman I, Kranias EG, Bohlmeyer T, Bristow MR, Lefkowitz RJ, Iaccarino G, Koch WJ, Leinwand LA. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest 107: 967-974, 2001.
12. Ganguly PK, Lee SL, Beamish RE, Dhalla NS. Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy. Am Heart J 118: 520-525, 1989.
13. Goldspink PH, Montgomery DE, Walker LA, Urboniene D, McKinney RD, Geenen DL, Solaro RJ, Buttrick PM. Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res 95: 424-432, 2004.
14. Gottle M, Geduhn J, Konig B, Gille A, Hocherl K, Seifert R. Characterization of mouse heart adenylyl cyclase. J Pharmacol Exp Ther 329: 1156-1165, 2009.
15. Gu X, Bishop SP. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res 75: 926-931, 1994.
16. Guillou JL, Nakata H, Cooper DM. Inhibition by calcium of mammalian adenylyl cyclases. J Biol Chem 274: 35539-35545, 1999.
17. Hamplová B, Novák F, Kolár F, Nováková O. Transient upregulation of protein kinase C in pressure-overloaded neonatal rat myocardium. Physiol Res 59: 25-33, 2010.
18. Hanoune J, Defer N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 41: 145-174, 2001.
19. Head BP, Patel HH, Roth DM, Lai NC, Niesman IR, Farquhar MG, Insel PA. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 280: 31036-31044, 2005.
20. Iwami G, Kawabe J, Ebina T, Cannon PJ, Homcy CJ, Ishikawa Y. Regulation of adenylyl cyclase by protein kinase A. J Biol Chem 270: 12481-12484, 1995.
21. sα overexpression. Am J Physiol Heart Circ Physiol 272: H585-H589, 1997.
22. Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ, Ishikawa Y. Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 269: 16554-16558, 1994.
23. Krell MJ, Kline EM, Bates ER, Hodgson JM, Dilworth LR, Laufer N, Vogel RA, Pitt B. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J 112: 787-791, 1986.
24. Lavandero S, Cartagena G, Guarda E, Corbalan R, Godoy I, Sapag-Hagar M, Jalil JE. Changes in cyclic AMP dependent protein kinase and active stiffness in the rat volume overload model of heart hypertrophy. Cardiovasc Res 27: 1634-1638, 1993.
25. Lee KW, Hong JH, Choi IY, Che Y, Lee JK, Yang SD, Song CW, Kang HS, Lee JH, Noh JS, Shin HS, Han PL. Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J Neurosci 22: 7931-7940, 2002.
26. + channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation. J Physiol 587: 1087-1100, 2009.
27. Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, Yatani A, Dorn GW 2nd. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101: 1707-1714, 2000. (Pubitemid 30196632)
28. Okumura S, Kawabe J, Yatani A, Takagi G, Lee MC, Hong C, Liu J, Takagi I, Sadoshima J, Vatner DE, Vatner SF, Ishikawa Y. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation. Circ Res 93: 364-371, 2003. (Pubitemid 37048249)
29. Okumura S, Suzuki S, Ishikawa Y. New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene. J Pharm Sci 109: 354-359, 2009.
30. Okumura S, Takagi G, Kawabe J, Yang G, Lee MC, Hong C, Liu J, Vatner DE, Sadoshima J, Vatner SF, Ishikawa Y. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci USA 100: 9986-9990, 2003. (Pubitemid 37087055)
31. Okumura S, Vatner DE, Kurotani R, Bai Y, Gao S, Yuan Z, Iwatsubo K, Ulucan C, Kawabe J, Ghosh K, Vatner SF, Ishikawa Y. Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation 116: 1776-1783, 2007. (Pubitemid 350287102)
32. Ostrom RS, Liu X, Head BP, Gregorian C, Seasholtz TM, Insel PA. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 62: 983-992, 2002. (Pubitemid 35222489)
33. 2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts. J Biol Chem 278: 24461-24468, 2003.
34. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL; the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 325: 1468-1475, 1991.
35. Palaniyandi SS, Sun L, Ferreira JC, Mochly-Rosen D. Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res 82: 229-239, 2009.
36. Palfi A, Bartha E, Copf L, Mark L, Gallyas F Jr, Veres B, Kalman E, Pajor L, Toth K, Ohmacht R, Sumegi B. Alcohol-free red wine inhibits isoproterenol-induced cardiac remodeling in rats by the regulation of Akt1 and protein kinase C alpha/beta II. J Nutr Biochem 20: 418-425, 2009.
37. Phan HM, Gao MH, Lai NC, Tang T, Hammond HK. New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy. Trends Cardiovasc Med 17: 215-221, 2007. (Pubitemid 47532726)
38. Piddo AM, Sanchez MI, Sapag-Hagar M, Corbalan R, Foncea R, Ebensperger R, Godoy I, Melendez J, Jalil JE, Lavandero S. Cyclic AMP-dependent protein kinase and mechanical heart function in ventricular hypertrophy induced by pressure overload or secondary to myocardial infarction. J Mol Cell Cardiol 28: 1073-1083, 1996. (Pubitemid 126334816)
39. Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J Jr, Lefkowitz RJ, Koch WJ. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci USA 95: 7000-7005, 1998. (Pubitemid 28278096)
40. Roth DM, Bayat H, Drumm JD, Gao MH, Swaney JS, Ander A, Hammond HK. Adenylyl cyclase increases survival in cardiomyopathy. Circulation 105: 1989-1994, 2002.
41. Siri FM. Sympathetic changes during development of cardiac hypertrophy in aortic-constricted rats. Am J Physiol Heart Circ Physiol 255: H452-H457, 1988.
42. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Mahara K, Iwata M, Hammond HK, Ogawa S. Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: a possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform. J Am Coll Cardiol 43: 125-132, 2004. (Pubitemid 38045926)
43. Tang T, Gao MH, Lai NC, Firth AL, Takahashi T, Guo T, Yuan JX, Roth DM, Hammond HK. Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation 117: 61-69, 2008. (Pubitemid 350291182)
44. Tang T, Lai NC, Roth DM, Drumm J, Guo T, Lee KW, Han PL, Dalton N, Gao MH. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation. Basic Res Cardiol 101: 117-126, 2006. (Pubitemid 43250803)
45. Tepe NM, Liggett SB. Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse. FEBS Lett 458: 236-240, 1999.
46. Tepe NM, Lorenz JN, Yatani A, Dash R, Kranias EG, Dorn GW 2nd, Liggett SB. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling. Biochemistry 38: 16706-16713, 1999. (Pubitemid 30007525)
47. Timofeyev V, He Y, Tuteja D, Zhang Q, Roth DM, Hammond HK, Chiamvimonvat N. Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy. J Mol Cell Cardiol 41: 170-181, 2006. (Pubitemid 43946968)
48. Vatner SF, Yan L, Ishikawa Y, Vatner DE, Sadoshima J. Adenylyl cyclase type 5 disruption prolongs longevity and protects the heart against stress. CIRC J 73: 195-200, 2009.
49. + channel expression and activity: novel insights from genetically altered mice. J Physiol 562: 745-758, 2005.
50. Yan L, Vatner DE, O'Connor JP, Ivessa A, Ge H, Chen W, Hirotani S, Ishikawa Y, Sadoshima J, Vatner SF. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 130: 247-258, 2007.